Study Says Byetta Side Effects Could Include Damage to the Pancreas, Notes Rottenstein Law Group

A recent study says that diabetes drug Byetta, manufactured by Amylin Pharmaceutical in conjunction with Eli Lilly and Company, could cause damage to the pancreaseven cancer. The Rottenstein Law Group, which is accepting clients in Byetta lawsuits, maintains a Byetta Legal Information Center on its website designed to provide more information on Byetta side effects and lawsuits.

New York, NY (PRWEB) March 25, 2013

The UCLA study showed increased evidence of pre-cancerous cellular changes associated with Type 2 diabetes treatments, according to Bloomberg. The increase in changes topped 40 percent. In 2007, two years after Byetta went to market, the U.S. Food and Drug Administration said it had received many reports of pancreatitis from Byetta users, the article said. The FDA recently issued a report** indicating it was evaluating the Byetta side effects claims of unpublished research studies.

Rochelle Rottenstein, principal of the Rottenstein Law Group, said that the growing body of evidence*** of Byettas alleged pancreatic side effects means that patients should be vigilant about their rights.

Patients trust drug companies to produce helpfulnot potentially harmfulmedications, Rottenstein said. It is important that patients understand that if they believe they have been harmed there are advocates available to help them navigate the system.

The Rottenstein Law Group encourages those who believe Byetta injured them to visit its website and contact the firm today.

*bloomberg.com/news/2013-03-22/diabetes-drugs-may-cause-damage-to-pancreas-study-finds.html

**http://www.fda.gov/Drugs/DrugSafety/ucm343187.htm

***usatoday30.usatoday.com/news/health/medical/health/medical/story/2011-09-23/Popular-diabetes-drugs-may-raise-pancreatic-cancer-risk-study-suggests/50531776/1

About THE ROTTENSTEIN LAW GROUP

Go here to see the original:
Study Says Byetta Side Effects Could Include Damage to the Pancreas, Notes Rottenstein Law Group